Clinical

Articles

An integrated review highlights the barriers standing between diverse LGBTQ populations and cancer screenings.

Overcoming Barriers to Cancer Screening in Diverse LGBTQ Populations

Seventeen years of data indicate that HPV-related cervical cancer incidence is declining, but other tumors related to the virus persist. 

Decline in HPV-Related Cervical Cancer May Inform Screening and Vaccination Guidance for Other Tumor Types 

Recommendations published in JAMA are set to change colorectal cancer screening guidance for all individuals in the United States. 

USPSTF Lowers the Recommended Age for CRC Screenings, Mandating Insurance Coverage 

In his "Letter to the Readers", co-editor-in-chief of the journal ONCOLOGY Howard S. Hochster, MD, reviews the utility of next-generation sequencing in pancreatic ductal adenocarcinoma.



Next-Generation Sequencing for Advanced Pancreatic Cancer: A Technology Whose Time Has NOT Come

CancerNetwork® reports on updates in prevention and earlier diagnosis of colorectal, breast, and other cancers.

CancerNetwork Honors World Health Day by Looking at Recent Breakthroughs in Cancer Prevention, Screening 

A novel imaging technology was cleared by the FDA to detect polyps with neoplastic potential during conduct of colonoscopy that aligns with pathological assessment with greater than 90% predictive ability. 

Narrow Band Imaging Earns FDA Clearance for Real-Time Assessment of Colorectal Polyps With Neoplastic Potential

The liquid biopsy assay RaDaR has been given a breakthrough device designation for use in the detection of minimal residual disease in early-stage cancers. 

RaDaR Assay Gets FDA Designation for Expediated Regulatory Pathway 

Investigators suggest that results of a study may help to identify concerns of individuals undergoing panel testing and ways to support their needs.

Psychological Responses to Genetic Counseling, Multigene Panel Testing Reveals Low Patients Distress, Uncertainty

Videos

The urologist at Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center spoke about the impact of a decline in cancer screening tests being performed during the first wave of the pandemic.

Quoc-Dien Trinh, MD, on Declines in Cancer & Precancer Diagnoses During COVID-19 Pandemic

The Breast Cancer Index assay is the only of its kind to be recommended in the National Comprehensive Cancer Network Guidelines for the treatment of breast cancer as being predictive of extended adjuvant endocrine therapy.

Screening | Topics